Basile Njei, MD, PhD, FRCP

2026

• A conceptual agentic AI architecture for MASLD-associated significant fibrosis in primary care.

  Njei B, Kanmounye US. A conceptual agentic AI architecture for MASLD-associated significant fibrosis in primary care. PLOS Digit Health 2026, 5: e0001500. PMID: 42348555, DOI: 10.1371/journal.pdig.0001500.

  Peer-Reviewed Original Research

• An Explainable AI Framework for Continuous Monitoring, Risk Stratification, and Clinical Decision Support in Primary Biliary Cholangitis: Protocol for a Multiphase Development and Validation Study.

  Njei B, Sidney Kanmounye U. An Explainable AI Framework for Continuous Monitoring, Risk Stratification, and Clinical Decision Support in Primary Biliary Cholangitis: Protocol for a Multiphase Development and Validation Study. JMIR Res Protoc 2026, 15: e89279. PMID: 42343691, DOI: 10.2196/89279.

  Peer-Reviewed Original Research

• National and state-level trends in digestive diseases in the United States, 1990 to 2021.

  Ta'ani OA, Alsakarneh S, Al-Ajlouni Y, Gabr A, Lahoud C, Danpanichkul P, Dahiya Singh D, Aburumman R, Alhalalmeh Y, Njei B. National and state-level trends in digestive diseases in the United States, 1990 to 2021. Proc (Bayl Univ Med Cent) 2026, 1-9. PMID: 42267772, DOI: 10.1080/08998280.2026.2674448.

  Peer-Reviewed Original Research

• Clinical Features and Outcomes of Lean Metabolic Dysfunction Associated Steatotic Liver Disease with Increased Alcohol Intake.

  John BV, Soon S, Singal A, Schwartz K, Liangpunsakul S, Alkhouri N, Wong RJ, Perumalswami P, Njei B, Noureddin M, Dahman B, Veterans Analysis of Liver Disease (VALID) group of investigators. Clinical Features and Outcomes of Lean Metabolic Dysfunction Associated Steatotic Liver Disease with Increased Alcohol Intake. Clin Gastroenterol Hepatol 2026 PMID: 42248436, DOI: 10.1016/j.cgh.2026.05.023.

  Peer-Reviewed Original Research

• Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

  GBD 2023 Diarrhoeal Disease and Enteric Infectious Diseases Collaborators. Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Infect Dis 2026 PMID: 42229499, DOI: 10.1016/S1473-3099(26)00194-5.

  Peer-Reviewed Original Research

• FibroX: a machine learning model for detecting and prognosticating advanced fibrosis in metabolic dysfunction-associated steatotic liver disease.

  Njei B, Al-Ajlouni YA, Ilagan-Ying Y, Al Ta'ani O, Boateng S, Njei N, Kanmounye US, Lim J, Banini B. FibroX: a machine learning model for detecting and prognosticating advanced fibrosis in metabolic dysfunction-associated steatotic liver disease. Transl Gastroenterol Hepatol 2026, 11: 67. PMID: 42291159, DOI: 10.21037/tgh-2026-0017.

  Peer-Reviewed Original Research

• Effect of coded steatotic liver disease on outcomes of percutaneous coronary intervention in non-diabetic adults: insights from a multicenter real-world cohort.

  Issaka Y, Maraqah M, Meyahnwi D, Adjei-Sefah K, Okorigba E, Oparah M, Boateng S, Abdul-Kareem H, Adefuye M, Nguefang GL, Njei B, Hahn S, Zarich S. Effect of coded steatotic liver disease on outcomes of percutaneous coronary intervention in non-diabetic adults: insights from a multicenter real-world cohort. BMC Cardiovasc Disord 2026 PMID: 42185950, DOI: 10.1186/s12872-026-06017-y.

  Peer-Reviewed Original Research

• An Explainable AI Tool (FibroX) for Detecting Advanced Liver Fibrosis in Adults With Type 2 Diabetes: Protocol for a Pilot Crossover Trial.

  Njei B, Kanmounye US. An Explainable AI Tool (FibroX) for Detecting Advanced Liver Fibrosis in Adults With Type 2 Diabetes: Protocol for a Pilot Crossover Trial. JMIR Res Protoc 2026, 15: e90456. PMID: 41974444, DOI: 10.2196/90456.

  Peer-Reviewed Original Research

• Large Language Models for Diagnosis and Prognosis of Chronic Liver Diseases: A Systematic Review.

  Njei B, Al-Ajlouni YA, Ajayi A, Shahin F, Ta'ani OA, Boateng S, Ketwaroo G, Protiva P. Large Language Models for Diagnosis and Prognosis of Chronic Liver Diseases: A Systematic Review. Health Sci Rep 2026, 9: e72476. PMID: 42089001, DOI: 10.1002/hsr2.72476.

  Peer-Reviewed Original Research

• A Multi-Phase Protocol for Developing and Validating an Explainable AI Framework for Continuous Monitoring, Risk Stratification, and Clinical Decision Support in Primary Biliary Cholangitis.

  Njei B, Sidney Kanmounye U. A Multi-Phase Protocol for Developing and Validating an Explainable AI Framework for Continuous Monitoring, Risk Stratification, and Clinical Decision Support in Primary Biliary Cholangitis. JMIR Res Protoc 2026 PMID: 42184424, DOI: 10.2196/89279.

  Peer-Reviewed Original Research